Synaptogenix Inc (SNPX)
4.53
+0.12
(+2.65%)
USD |
NASDAQ |
Apr 26, 16:00
4.385
-0.14
(-3.20%)
After-Hours: 20:00
Synaptogenix Price: 4.53 for April 26, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 26, 2024 | 4.54 | 4.54 | 4.34 | 4.53 | 6924.00 |
Apr 25, 2024 | 4.45 | 4.60 | 4.413 | 4.413 | 3503.00 |
Apr 24, 2024 | 4.58 | 4.690 | 4.481 | 4.56 | 14442.00 |
Apr 23, 2024 | 4.39 | 4.79 | 4.381 | 4.57 | 40601.00 |
Apr 22, 2024 | 4.50 | 4.50 | 4.200 | 4.36 | 53626.00 |
Apr 19, 2024 | 4.64 | 4.71 | 4.252 | 4.33 | 29905.00 |
Apr 18, 2024 | 4.73 | 4.95 | 4.60 | 4.66 | 42233.00 |
Apr 17, 2024 | 4.69 | 4.959 | 4.375 | 4.80 | 121996.0 |
Apr 16, 2024 | 4.50 | 4.89 | 4.43 | 4.650 | 93298.00 |
Apr 15, 2024 | 4.72 | 4.80 | 4.42 | 4.42 | 95422.00 |
Apr 12, 2024 | 4.83 | 5.037 | 4.57 | 4.686 | 82800.00 |
Apr 11, 2024 | 4.71 | 5.07 | 4.61 | 4.825 | 72575.00 |
Apr 10, 2024 | 4.85 | 4.920 | 4.55 | 4.70 | 56627.00 |
Apr 09, 2024 | 5.78 | 5.95 | 4.772 | 4.94 | 249929.0 |
Apr 08, 2024 | 4.81 | 6.217 | 4.77 | 5.39 | 276929.0 |
Apr 05, 2024 | 4.15 | 5.35 | 4.15 | 5.000 | 137673.0 |
Apr 04, 2024 | 4.288 | 5.125 | 4.288 | 4.525 | 47616.00 |
Apr 03, 2024 | 4.635 | 4.682 | 3.865 | 4.50 | 69327.00 |
Apr 02, 2024 | 4.72 | 4.858 | 4.275 | 4.598 | 5702.00 |
Apr 01, 2024 | 4.825 | 4.85 | 4.50 | 4.592 | 4278.00 |
Mar 28, 2024 | 4.975 | 5.125 | 4.688 | 4.688 | 4935.00 |
Mar 27, 2024 | 4.96 | 5.172 | 4.75 | 4.762 | 5393.00 |
Mar 26, 2024 | 4.65 | 5.088 | 4.458 | 4.95 | 10695.00 |
Mar 25, 2024 | 4.495 | 4.942 | 4.19 | 4.571 | 31690.00 |
Mar 22, 2024 | 4.752 | 5.00 | 4.65 | 4.678 | 7234.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.965
Minimum
Feb 13 2024
343.00
Maximum
Oct 12 2021
121.74
Average
151.00
Median
Dec 05 2022
Price Benchmarks
CEL-SCI Corp | 1.44 |
AIM ImmunoTech Inc | 0.4282 |
IGC Pharma Inc | 0.458 |
NovaBay Pharmaceuticals Inc | 0.0788 |
Protalix BioTherapeutics Inc | 1.15 |
Price Related Metrics
Price to Book Value | 0.2019 |
Earnings Yield | -955.3% |
Market Cap | 4.916M |